Pricing

Innoviva Inc (INVA)

followers ·
Sector: HEALTH CARE
Industry: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Pavel Raifeld
Employees: 100
Web site: inva.com
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
6502389600
    Formally known as:
  • Theravance Inc

Are you looking for this stock instead?

All 13F Filers Prior Change Hedge Funds 1 Prior Change
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available